Research Paper Volume 13, Issue 2 pp 2780—2802

Identification of a novel immune microenvironment signature predicting survival and therapeutic options for bladder cancer

Risk-stratified analysis of the 10-gene signature for overall survival of bladder cancer patients. Kaplan-Meier curves for overall survival of patients in Age (≤65-year-old) subgroup (A), Age (>65-year-old) group (B), Female subgroup (C), Male subgroup (D), N0 subgroup (E), N1-N3 subgroup (F), clinical stage I-II subgroup (G), clinical stage III-IV subgroup (H), T1-2 subgroup (I), T3-4 subgroup (J), M0 subgroup (K), M1 subgroup (L).

Figure 6. Risk-stratified analysis of the 10-gene signature for overall survival of bladder cancer patients. Kaplan-Meier curves for overall survival of patients in Age (≤65-year-old) subgroup (A), Age (>65-year-old) group (B), Female subgroup (C), Male subgroup (D), N0 subgroup (E), N1-N3 subgroup (F), clinical stage I-II subgroup (G), clinical stage III-IV subgroup (H), T1-2 subgroup (I), T3-4 subgroup (J), M0 subgroup (K), M1 subgroup (L).